In the present study, we investigated the expression level of IL-33 (and ST2) in the adipose tissue, as well as its association with various immune and metabolic parameters, in individuals with normoglycemia, prediabetes, and T2D. This evidence concerns the gene IL33 and type 2 diabetes mellitus.